Back to top
more

Defiance Daily Target 2x Long LMND ETF: (LMNX)

(Delayed Data from NASDAQ) As of Feb 27, 2026 03:32 PM ET

$13.16 USD

13.1625
58,575

-2.03 (-13.35%)

Volume: 58,575

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $13.28 +0.12 (0.89 %) 4:47 PM ET

Zacks News

Zacks Equity Research

Hill-Rom Holdings Hits 52-Week High on Solid Product Line

Share price of Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) scaled a new 52-week high of $78.51 on Jun 1.

    Zacks Equity Research

    The Cooper Companies (COO) Beats Earnings Estimates in Q2

    The Cooper Companies Inc. (COO) reported adjusted earnings of $2.50 in second-quarter fiscal 2017, surpassing the Zacks Consensus Estimate by 25 cents and improving from $2.05 in the year-ago quarter.

      Zacks Equity Research

      Edwards Lifesciences' TAVR & International Prospects Solid

      On Jun 2, we issued an updated research report on leading molecular diagnostic company, Edwards Lifesciences Corporation (EW).

        Zacks Equity Research

        Patterson Companies Grapples With Multiple Issues: Dump Now?

        On Jun 2, we issued an updated research report on St. Paul, MN-based The Patterson Companies (PDCO), a leading distributor of the dental, companion-pet veterinarian and rehabilitation supply markets.

          Zacks Equity Research

          Medtronic Starts PRODIGY Study on Respiratory Compromise

          Medtronic plc (MDT) recently introduced a new global study on opioid induced respiratory depression (OIRD), a preventable form of respiratory compromise.

            Zacks Equity Research

            Genomic Health to Unveil Oncotype DX Study Results at ASCO

            Global cancer research company Genomic Health, Inc. (GHDX) will be presenting results from eight Oncotype DX studies at American Society of Clinical Oncology (ASCO) in Chicago.

              Zacks Equity Research

              3 Medical Device Stocks with Solid Potential to Buy Now

              The Medical Device industry has been riding high on optimism of late, courtesy of the Senate's latest decision to lacerate the Affordable Care Act (ACA) by the end of July.

                Zacks Equity Research

                Align Technology Upgrades iTero Element Intraoral Scanners

                Based in California, leading dental product maker Align Technology, Inc. (ALGN) recently announced a software upgrade to its iTero Element intraoral scanners.

                  Zacks Equity Research

                  LabCorp Trades Down on Weak 2017 View, Reimbursement Woes

                  On May 30, we issued an updated research report on Burlington, NC-based Laboratory Corporation of America Holdings (LH).

                    Zacks Equity Research

                    Becton, Dickinson at 52-Week High: What's Driving the Stock?

                    Share price of Becton, Dickinson and Company (BDX), based in Franklin Lakes, NJ, Becton, scaled a new 52-week high of $188.48 on May 30, eventually closing a bit lower at $188.07.